Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 234 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact234 DOIs

Add abstracts to 78 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact78 DOIs

Deposit reference lists for 18 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact18 DOIs

DOIs for this ISSN

Showing the top 5 of 600 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	The ABCD of clinical pharmacokinetics (10.1177/2042098612469335)	Abstract ORCID	103.59	117
2	Can supporting health literacy reduce medication-related har… (10.1177/2042098618754482)	Abstract ORCID	82.17	43
3	Antimicrobial resistance: risk associated with antibiotic ov… (10.1177/2042098614554919)	ORCID	80.10	1599
4	The hope, hype and reality of Big Data for pharmacovigilance (10.1177/2042098617736422)	Abstract ORCID	77.82	35
5	The SENATOR project: developing and trialling a novel softwa… (10.1177/2042098616675851)	Abstract ORCID	71.57	26
6	Digital necrosis: a potential risk of high-dose norepinephri… (10.1177/2042098617712669)	Abstract ORCID	69.90	24
7	Safety evaluation and risk assessment of electronic cigarett… (10.1177/2042098614524430)	ORCID	67.58	504
8	Predicting risk of adverse drug reactions in older adults (10.1177/2042098615615472)	ORCID	64.21	369
9	The pale evidence for treatment of iron-deficiency anaemia i… (10.1177/2042098618769568)	Abstract ORCID	62.76	17
10	Dexmedetomidine-associated fever in the intensive care unit (10.1177/2042098615612661)	Abstract ORCID	61.52	16
11	Drug-induced QT interval prolongation: mechanisms and clinic… (10.1177/2042098612454283)	ORCID	60.50	262
12	Pharmacists in Australian general practice: an opportunity f… (10.1177/2042098615599947)	Abstract ORCID	60.21	15
13	Cardiovascular risk with DPP-4 inhibitors: latest evidence a… (10.1177/2042098615623915)	Abstract ORCID	60.21	15
14	Pharmacogenetics and precision medicine: Is inflammation a c… (10.1177/2042098617712657)	Abstract ORCID	60.21	15
15	Recent advances in the utility and use of the General Practi… (10.1177/2042098611435911)	ORCID	60.08	252
16	hERG potassium channel inhibition by ivabradine may contribu… (10.1177/2042098615595546)	Abstract ORCID	58.80	14
17	Adverse effects of proton-pump inhibitor use in older adults… (10.1177/2042098617715381)	ORCID	57.14	192
18	Drug-related falls in older patients: implicated drugs, cons… (10.1177/2042098613486829)	ORCID	56.74	185
19	Safety of antipsychotics for the treatment of schizophrenia:… (10.1177/2042098618756261)	ORCID	56.56	182
20	The risks of long-term use of proton pump inhibitors: a crit… (10.1177/2042098618809927)	ORCID	56.38	179
21	Nonmedical prescribing: where are we now? (10.1177/2042098616646726)	ORCID	56.08	174
22	Pregabalin: latest safety evidence and clinical implications… (10.1177/2042098613505614)	ORCID	55.50	165
23	Proton pump inhibitors and risk of vitamin and mineral defic… (10.1177/2042098613482484)	ORCID	55.10	159
24	Medication-overuse headache: epidemiology, diagnosis and tre… (10.1177/2042098614522683)	ORCID	54.83	155
25	Review of naloxone safety for opioid overdose: practical con… (10.1177/2042098614564776)	ORCID	53.50	137
26	Safety of antiobesity drugs (10.1177/2042098613489721)	ORCID	53.26	134
27	Combined hormonal contraceptives: prescribing patterns, comp… (10.1177/2042098614548857)	ORCID	52.85	129
28	New generation antiepileptic drugs: what do they offer in te… (10.1177/2042098611411127)	ORCID	51.33	112
29	Safety of dipeptidyl peptidase 4 inhibitors: a perspective r… (10.1177/2042098614523031)	ORCID	51.33	112
30	Cardiovascular toxicity associated with adjuvant trastuzumab… (10.1177/2042098614529603)	ORCID	50.73	106
31	Polypharmacy and inappropriate medication use in patients wi… (10.1177/2042098616670798)	ORCID	50.22	101
32	Routine deprescribing of chronic medications to combat polyp… (10.1177/2042098615613984)	ORCID	49.67	96
33	Immunogenicity and other problems associated with the use of… (10.1177/2042098611406318)	ORCID	49.44	94
34	Specific features of medicines safety and pharmacovigilance… (10.1177/2042098611425695)	ORCID	47.98	82
35	Safety of statins: an update (10.1177/2042098612439884)	ORCID	47.85	81
36	Antipsychotic drugs in pregnancy: a review of their maternal… (10.1177/2042098614522682)	ORCID	47.85	81
37	Cardiovascular and cerebrovascular risk with nonsteroidal an… (10.1177/2042098617690485)	ORCID	47.85	81
38	Pharmacogenomic substudies of randomized controlled trials:… (10.1177/2042098613520030)	Abstract ORCID	47.71	8
39	Using deep learning to improve medication safety: the untapp… (10.1177/2042098617729318)	Abstract ORCID	47.71	8
40	Accessing social media information for pharmacovigilance: wh… (10.1177/2042098618778191)	Abstract ORCID	47.71	8
41	Adverse effects of testosterone replacement therapy: an upda… (10.1177/2042098614548680)	ORCID	47.58	79
42	Suvorexant in insomnia: efficacy, safety and place in therap… (10.1177/2042098615595359)	ORCID	47.58	79
43	Topiramate and cognitive impairment: evidence and clinical i… (10.1177/2042098612455357)	ORCID	46.88	74
44	Medication safety in neonatal care: a review of medication e… (10.1177/2042098616642231)	ORCID	46.88	74
45	Mirabegron in overactive bladder patients: efficacy review a… (10.1177/2042098616659412)	ORCID	46.88	74
46	Poly-de-prescribing to treat polypharmacy: efficacy and safe… (10.1177/2042098617736192)	ORCID	46.58	72
47	Precision medicine: does ethnicity information complement ge… (10.1177/2042098617743393)	ORCID	46.28	70
48	A pilot randomized controlled trial of deprescribing (10.1177/2042098611400332)	ORCID	46.13	69
49	Medication use and potentially inappropriate prescribing in… (10.1177/2042098618782785)	ORCID	46.13	69
50	New antiepileptic medication linked to blue discoloration of… (10.1177/2042098614560736)	ORCID	45.81	67